Sales rise 12.54% to Rs 2204.22 crore
Net profit of Piramal Pharma declined 63.60% to Rs 3.68 crore in the quarter ended December 2024 as against Rs 10.11 crore during the previous quarter ended December 2023. Sales rose 12.54% to Rs 2204.22 crore in the quarter ended December 2024 as against Rs 1958.57 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales2204.221958.57 13 OPM %15.3213.70 -PBDT263.61237.95 11 PBT66.8051.63 29 NP3.6810.11 -64Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
